سعر هاي بيوتك ان 600مجم معلق 80 مل 600 مجم/5 مل 2024

Amoxicillin + clavulanic acid 600 mg/5 ml (600 mg + 42.9 mg per 5 ml) powder for oral suspension, 80 ml bottle, by Amoun (Egypt); a penicillin antibiotic combined with a beta-lactamase inhibitor.

• Children aged 3 months to 12 years weighing 40 kg or less with recurrent or persistent acute otitis media due to S. pneumoniae (penicillin MIC 2 mcg/mL or less), H. influenzae or M. catarrhalis (including beta-lactamase-producing strains), with antibacterial exposure for otitis media in the previous 3 months and either age 2 years or younger or day-care attendance.Population: Pediatric patients 3 months to 12 years, 40 kg or lessDailyMed (U.S. National Library of Medicine)

• Most frequently reported (over 4%): coughing, vomiting, contact dermatitis (diaper rash), fever, upper respiratory tract infection and diarrhoea.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• History of a serious hypersensitivity reaction (e.g. anaphylaxis or Stevens-Johnson syndrome) to amoxicillin, clavulanate or other beta-lactams (penicillins or cephalosporins).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Serious (including fatal) hypersensitivity reactions: discontinue if a reaction occurs and institute appropriate therapy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Severe cutaneous adverse reactions (SCAR): monitor closely and discontinue if the rash progresses.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Drug-induced enterocolitis syndrome (DIES) has been reported with amoxicillin; discontinue and treat if it occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• ProbenecidDecreases renal tubular secretion of amoxicillin, giving higher and prolonged amoxicillin levels; co-administration is not recommended.DailyMed (U.S. National Library of Medicine)
• Oral anticoagulantsAbnormal prolongation of prothrombin time (increased INR) has been reported; monitor and adjust the anticoagulant dose if needed.DailyMed (U.S. National Library of Medicine)
• AllopurinolConcurrent use increases the incidence of rash.DailyMed (U.S. National Library of Medicine)

• Published epidemiologic studies and pharmacovigilance reports over several decades have not established a drug-associated risk of major birth defects, miscarriage or adverse maternal outcomes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• In women with preterm prelabour rupture of membranes, prophylactic amoxicillin/clavulanate may be associated with an increased risk of necrotising enterocolitis in neonates.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.